Fundraising Fox

Biotech Late Stage Investors & VC Firms

652 firms in this list, with a median first check of $1M. 131 of them lead rounds. Generated from verified public data and updated continuously.

Novo Holdings
CopenhagenPre-Seed–Late Stage$1.1M – $54M
47 people
Cambridge Innovation Capital
CambridgeSeed–Late Stage$127K – $12.7M
58 people
Bain Capital Life Sciences
BostonSeries B–Late Stage
47 people
Electric Capital
Palo AltoPre-Seed–Late Stage$1M – $20M
37 people
NVIDIA
Santa ClaraPre-Seed–Late Stage
22 people
HLM Venture Partners
BostonSeed–Late Stage$3M – $5M
33 people
5AM Ventures
BostonSeed–Late Stage$100K – $4M
39 people
Stifel Venture Banking
St. LouisSeed–Late Stage
75 people
Versant Ventures
San FranciscoSeed–Late Stage$250K – $5M
48 people
Advent International
BostonSeries A–Late Stage$1.1B
61 people
Pfizer Venture Investments
Seed–Late Stage$5M – $20M
18 people
Sixth Street
San FranciscoPre-Seed–Late Stage$50M – $2.5B
44 people
TPG
San FranciscoGrowth–Late Stage
53 people
Nippon Venture Capital
TokyoPre-Seed–Late Stage$1.5M – $269M
MPM BioImpact
BostonPre-Seed–Late Stage$1M – $15M
50 people
Clairvest Group Inc
TorontoGrowth–Late Stage$25M – $100M
58 people
Premji Invest
Menlo ParkSeed–Late Stage
35 people
Sofina
BrusselsSeed–Late Stage$100M – $300M
57 people
Artesian
SydneyPre-Seed–Late Stage$20M
39 people
Basecamp Fund
ManchesterPre-Seed–Late Stage$100K – $10M
12 people
Catalio Capital Management, LP
New YorkSeed–Late Stage
36 people
Meusinvest (Noshaq)
LiegeSeed–Late Stage
67 people
Celesta Capital
Menlo ParkSeed–Late Stage$5M – $20M
33 people
Inveready Technology Investment Group
San SebastiánPre-Seed–Late Stage$108K – $21.6M
63 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.